Urinary excretion of the collagen cross-link pyridinoline increases during liver fibrogenesis

Journal of Hepatology

Volumn 26, Issue 6, 1997, Pages 1356-1362

  Grenard, Pascale ^a   Blanquier, Bariza ^a   Ricard Blum, Sylvie ^a  

^a NONE

Author keywords

Collagen; Cross linking; Liver fibrosis; Pyridinoline; Schistosomiasis

Indexed keywords

ANTIPARASITIC AGENT; COLLAGEN; PRAZIQUANTEL; PYRIDINOLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CROSS LINKING; LIVER FIBROSIS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; URINARY EXCRETION;

EID: 0030785825     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80472-2     Document Type: Article

References (29)

1. Gressner AM. Liver fibrosis: perspectives in pathobiochemical research and clinical outlook. Eur J Clin Chem Clin Biochem. 29:1991;293-11.
2. Ricard-Blum S, Bresson-Hadni S, Vuitton DA, Ville G, Grimaud JA. Hydroxypyridinium collagen cross-links in human liver fibrosis: study of alveolar echinococcosis. Hepatology. 15:1992;599-602.
3. Ricard-Blum S, Ville G, Grimaud JA. Pyridinoline, a mature collagen cross-link, in fibrotic livers from Schistosoma mansoni-infected mice. Am J Trop Med Hyg. 47:1992;816-820.
4. Ricard-Blum S, Liance M, Houin R, Grimaud JA, Vuitton DA. Covalent crosslinking of liver collagen by pyridinoline increases in the course of experimental alveolar echinococcosis. Parasite. 2:1995;113-118.
5. Ricard-Blum S, Bresson-Hadni S, Guerret S, Grenard P, Volle PJ, Risteli L, Grimaud JA, Vuitton DA. Mechanism of collagen network stabilization in human irreversible granulomatous liver fibrosis. Gastroenterology. 111:1996;172-182.
6. Clément B, Loréal O, Levavasseur F, Guillouzo A. New challenges in hepatic fibrosis. J Hepatol. 18:1993;1-4.
7. Risteli J, Risteli L. Analysing connective tissue metabolites in human serum. Biochemical, physiological and methodological aspects. J Hepatol. 22:1995;77-81. (Suppl 2).
8. Schuppan D, Stölzel U, Oesterling C, Somasundaram R. Serum assays for liver fibrosis. J Hepatol. 22:1995;82-88. (Suppl 2).
9. Gunja-Smith Z, Boucek RJ. Collagen cross-linking compounds in human urine. Biochem J. 197:1981;759-762.
10. Boros DL. IMmunopathology of Schistosoma mansoni infection. Clin Microbiol Rev. 2:1989;250-269.
11. Wyler DJ. Why does liver fibrosis occur in schistosomiasis? Parasitology Today. 8:1992;277-279.
12. James S, Colley D. Schistosomiasis. Curr Op Infect Dis. 8:1995;351-355.
13. Brindley PJ. Relationships between chemotherapy and immunity in schistosomiasis. Adv Parasit. 34:1994;133-161.
14. Kumar V, Gryseels B. Use of praziquantel against schistosomiasis: a review of current status. Int J Microbiol Agents. 4:1994;313-320.
15. Andrade ZA, Grimaud JA. Evolution of the schistosomal hepatic lesions in mice after curative chemotherapy. Am J Pathol. 124:1986;59-65.
16. Brindley PJ, Sher A. The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response. J Immunol. 139:1987;215-220.
17. Pellegrino J, Brener Z. Method for isolating schistosome granulomas from mouse liver. J Parasitol. 42:1976;564.
18. Black D, Duncan A, Robins SP. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquide chromatography. Anal Biochem. 169:1988;197-3.
19. Colwell A, Russell RGG, Eastsell R. Factors affecting the assay of 3-hydroxypyridinium crosslinks of collagen as markers of bone resorption. Eur J Clin Invest. 23:1993;341-349.
20. Woessner JT. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys. 93:1961;440-447.
21. Morcos SH, Khayyal MT, Mansour MM, Saleh S, Ishak EA, Girgis NI, Dunn MA. Reversal of hepatic fibrosis after praziquantel therapy of murine schistosomiasis. Am J Trop Med Hyg. 34:1985;314-321.
22. Morcos SH, Mansour MM, Khayyal MT, Saleh S, Ishak EA, Girgis NI. Evaluation of hepatic fibrosis after oxamniquine therapy of murine schistosomiasis. Ann Trop Med Parasitol. 86:1992;511-516.
23. Kresina TF, He Q, Degli Esposti S, Zern MA. Gene expression of transforming growth factor β1 and extracellular matrix proteins in murine Schistosoma mansoni infection. Gastroenterology. 107:1994;773-780.
24. Nishimura M, Asahi M, Hayashi M, Takazono I, Tanaka Y, Kohda H, Urabe H. Extracellular matrix in hepatic granulomas of mice infected with Schistosoma mansoni. Arch Pathol Lab Med. 109:1985;813-818.
25. Ricard-Blum S, Chossegros P, Guerret S, Trepo M, Grumaud JA, Chevallier M. The carboxy-terminal cross-linked telopeptide of type I collagen (ICTP) is a potential marker of ongoing liver fibrosis. Clin Chim Acta. 248:1996;187-195.
26. Schiltz JR, Olds GR, Kresina TF, Mahmoud AAF. Effect of chemotherapy on hepatic collagen and glycosaminoglycan metabolism in Schistosoma mansoni-infected mice. Trans Roy Soc Trop Med Hyg. 82:1988;868-873.
27. Cheever AW, Macedonia JG, Deb S, Cheever EA, Mosimann JE. Persistence of eggs and hepatic fibrosis after treatment of Schistosoma mansoni-infected mice. Am J Trop Med Hyg. 46:1992;752-758.
28. Murphy G, Reynolds JJ. Extracellular matrix degradation. Royce PM, Steinmann B. Connective Tissue and its Heritable Disorders. 287-16:1993;Wiley Liss Inc. New York.
29. Vater CA, Harris ED, Siegel RC. Native cross-links in collagen fibrils induce resistance to human synovial collagenase. Biochem J. 181:1979;639-645.